Pietro Nargi, an analyst from Intermonte, reiterated the Buy rating on Esprinet Spa. The associated price target is €6.70.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pietro Nargi has given his Buy rating due to a combination of factors that highlight Esprinet Spa’s strong performance and positive outlook. The company’s second-quarter results surpassed expectations, showcasing a notable improvement in its market outlook compared to the first quarter. This has led to an upward revision of earnings estimates, with an average increase of 9% in EPS over the next three years, aligning with the optimistic guidance provided by management.
Esprinet Spa’s revenue mix has improved, driven by significant growth in value-added segments such as Solutions and the green tech division, Zeliatech. Despite challenges in the Devices segment, the company has maintained solid performance in other areas. The management’s reaffirmation of the full-year EBITDA guidance and their confidence in achieving the upper end of the range further support the positive outlook. Consequently, the target price for Esprinet Spa has been raised from €6.30 to €6.70, reflecting the company’s potential for future growth.
According to TipRanks, Nargi is ranked #4811 out of 9983 analysts.
In another report released on September 13, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a €6.50 price target.